Revision history of "ANTIBIOTIC MEDICINAL SUSPENSION FOR INJECTION" (Q104324)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 06:0906:09, 9 October 2024DG Regio talk contribs 88,531 bytes +1 Changed label, description and/or aliases in pt
  • curprev 06:0906:09, 9 October 2024DG Regio talk contribs 88,530 bytes −269 Set a claim value: summary (P836): O objectivo directo é implementar a produção com base nos resultados da própria I & D e a introdução de um novo medicamento genérico no mercado farmacêutico e melhorar o processo tecnológico dos medicamentos produzidos até à data. Tal contribuirá para a realização do objetivo estratégico da empresa, que consiste em melhorar sistematicamente a sua posição no mercado farmacêutico veterinário na Polónia e na Europa através do desenvolvimento da gama. A...

22 March 2024

15 January 2024

12 June 2023

24 May 2023

2 March 2023

27 October 2022

26 October 2022

21 October 2022

2 July 2022

  • curprev 12:4312:43, 2 July 2022DG Regio talk contribs 80,123 bytes +50,423 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

18 January 2022

15 January 2022

17 December 2021

7 December 2021

1 December 2021

  • curprev 09:0509:05, 1 December 2021DG Regio talk contribs 17,327 bytes +3,196 Created claim: summary (P836): L’objectif direct est de mettre en œuvre dans la production sur la base des résultats de ses propres travaux de R & D et de lancer un nouveau médicament générique sur le marché pharmaceutique et d’améliorer le processus technologique des médicaments produits jusqu’à présent. Cela contribuera à l’objectif stratégique de l’entreprise d’améliorer systématiquement sa position sur le marché de la pharmacie vétérinaire en Pologne et en Europe grâce au...
  • curprev 09:0509:05, 1 December 2021DG Regio talk contribs 14,131 bytes +113 Changed label, description and/or aliases in fr: translated_label

29 October 2020

17 October 2020

  • curprev 16:4616:46, 17 October 2020DG Regio talk contribs 14,457 bytes +104 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 16:4616:46, 17 October 2020DG Regio talk contribs 14,353 bytes −111 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 16:4616:46, 17 October 2020DG Regio talk contribs 14,464 bytes +2,641 Created claim: summary (P836): The direct goal is to implement the production on the basis of the results of own R & D and the introduction of a new generic drug to the pharmaceutical market and to improve the technological process of the medicines produced so far. This will contribute to the realisation of the Company’s strategic goal, which is to systematically improve its position in the veterinary pharmaceutical market in Poland and in Europe through the development of th...
  • curprev 16:4616:46, 17 October 2020DG Regio talk contribs 11,823 bytes −2,349 Removed claim: summary (P836): The direct objective is to produce on the basis of the results of its own R & D work and to introduce a new generic medicine on the pharmaceutical market and to improve the technological process of existing medicines. This will contribute to the Company’s strategic objective of systematically improving the position in the veterinary pharmaceutical market in Poland and in Europe by developing its product range. The task that the company wants t...

23 September 2020

22 June 2020

10 June 2020

7 June 2020

26 March 2020

9 March 2020

  • curprev 09:1509:15, 9 March 2020DG Regio talk contribs 12,895 bytes +2,349 Created claim: summary (P836): The direct objective is to produce on the basis of the results of its own R & D work and to introduce a new generic medicine on the pharmaceutical market and to improve the technological process of existing medicines. This will contribute to the Company’s strategic objective of systematically improving the position in the veterinary pharmaceutical market in Poland and in Europe by developing its product range. The task that the company wants to...

24 February 2020

18 February 2020

31 January 2020

14 January 2020